Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

Trial StartEnlighten®Positive

AI Analysis

Summary

Proteotype Diagnostics launched the INNOVATOR study, a €3 million European trial to validate the Enlighten® multi-cancer detection test across 12 cancers and evaluate home-based capillary blood collection methods.

Clinical Trial Data

Importance:5/10

Sentiment:

0.60

cancer detectiondiagnostic testhome blood collectionclinical studyEurope

Related Companies

$FVNNU

Read the original article

Published by PR Newswire Biotech on July 30, 2026 6:07 PM

Read Original